Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (231)	6/23/2004 4:47:23 PM
From: Icebrg	Read Replies (1) of 946

>>Huh?>> Early, generally small, shot-gun type of trials to find out if the drug might give some benefits in a wide variety of different tumors. Gives the impression that the investigators are not really sure about what they should be looking for. Trisenox may well bring benefits in solid cancers, but we will have to wait for conclusion of these trials before we know more. The drug is interesting as both its side-effect profile and mode of action might differ from the "nomal" chemotherapies. It might very well find a niche in various types of drug combinations. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next